Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

Join Prof. Jessica Lin as she explores key strategies for managing ALK+ NSCLC while prioritizing long-term patient safety

Speaker : Prof. Jessica Lin

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Explore how CDK4/6 inhibitors improve overall survival in HR+/HER2- advanced breast cancer patients with Dr. Anju Malhotra.

Speakers : Dr. Anju Malhotra

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

Explore advanced urothelial carcinoma treatment strategies with Dr. Nagender Sharma. Discover immunotherapy, targeted therapies, and personalized approaches in this expert-led oncology discussion.

Speakers : Dr Nagendra Sharma

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Explore the hospitalization burden, healthcare impact, and resource demands in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Learn about early relapse in B-cell ALL, including relapse rates within the first year, key risk factors, and the most common sites like bone marrow and CNS.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Exploring novel therapies and redefining long-term survival outcomes in adult relapsed/refractory B-cell ALL through precision and immunotherapy.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Explore optimal first-salvage therapies for adult R/R B-Cell ALL with high disease burden, advancing remission and personalized treatment.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

xplore MRD-guided therapies in adult R/R B-ALL, with insights on CAR-T, blinatumomab, and personalized strategies for achieving long-term remission.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Discover groundbreaking treatments offering new hope for adults with relapsed B-cell ALL. Explore the latest advances, therapies, and strategies transforming outcomes in this challenging leukemia.

Speakers : Dr Riyaz Ahmed ,Dr Isha Kaul ,Dr Nitin Gupta

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Explore the unmet needs in ALK-positive NSCLC with Dr. Vamshi Krishna M as he discusses current challenges, treatment gaps, and future directions in lung cancer care.

Speakers : Dr. Vamsi Krishna M

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M


Recommended News For You

Losing a reward can affect your motivation and performance.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

The biology of cancer as well as potential treatment options are examined by experts.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Recommended Articles For You

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition 

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer 

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health 

Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

2.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

3.

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

4.

Year in Review: Non-Small Cell Lung Cancer

5.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

1.

What Is Carboxyhemoglobin And How Can It Affect Your Health?

2.

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment 

3.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

4.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

5.

The Importance of Having a Quick and Effective Heparin Antidote 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

2.

Navigating the Complexities of Ph Negative ALL - Part XVI

3.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot